Meeting
2022 ASCO Annual Meeting
Comprehensive genomic profiling (CGP) of chromophobe renal cell carcinoma (chrRCC) compared with non-chromophobe RCC (nonchrRCC): Impact of FLCN genomic alteration (GA) status.
Authors
Gennady Bratslavsky
SUNY Upstate Medical University, Syracuse, NY
Gennady Bratslavsky , Andrea Necchi , Petros Grivas , Joseph M Jacob , Oleksandr Kravtsov , Richard S.P. Huang , Natalie Danziger , Jeffrey S. Ross
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4550)
DOI
10.1200/JCO.2022.40.16_suppl.4550
Abstract #
4550
Poster Bd #
41
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
PBRM1 mutation and immunotherapy efficacy: A comprehensive genomic profiling (CGP) assessment.
First Author: Gennady Bratslavsky
Poster
2024 ASCO Genitourinary Cancers Symposium
Malignant epithelioid angiomyolipoma (eAML)/PEComa of the kidney: A genomic landscape study.
First Author: Rebecca A Sager
Poster
2022 ASCO Annual Meeting
Association between tumor mutational burden (TMB) and mutational profile and its effect on overall survival: A post hoc analysis of patients with TMB-high and TMB-low metastatic cancer treated with immune checkpoint inhibitors (ICI).
First Author: Camila Bragança Xavier
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of PD-L1 expression on conventional urothelial bladder carcinoma (UBC) genomic alteration (GA) profile.
First Author: Petros Grivas